Menu

ISTOCK, DRA_SCHWARTZ

CRISPR Gene Drive Used to Alter Mouse Coat Color

It’s the first demonstration of the technology in mammals.

Jul 9, 2018
Shawna Williams

In a preprint posted to bioRxiv last week (July 4), researchers at the University of California, San Diego, report using a CRISPR-Cas9 gene drive in mammals for the first time. Gene drives ensure that offspring preferentially inherit one parent’s particular allele, so that a variant can quickly spread through a population even if it is detrimental to reproduction or survival. The UCSD researchers were able to get a drive to work in the germlines of developing female mice, but only some of the time; on average, the offspring inherited the desired allele 73 percent of the time (as opposed to the typical 50 percent without a gene drive).

“These results demonstrate that the CRISPR/Cas9 gene drive mechanism can be implemented to simplify complex genetic crosses in laboratory mice and also contribute valuable data to the ongoing debate about applications to combat invasive rodent populations in island communities,” the authors write in their report.

See “Using Gene Drives to Limit the Spread of Malaria

Gene drives have drawn wide attention and controversy for their potential to help control disease-carrying mosquito populations by spreading alleles that cause infertility. The new study breaks fresh ground by exploring whether the CRISPR-Cas9 editing technique can successfully implement a gene drive in mammals—in this case, by spreading a gene for white coat color. The results are “an indication it could work, but it’s also sobering,” geneticist Paul Thomas of the University of Adelaide in Australia who was not involved in the research tells Nature. “It’s a lot longer to go where you could consider gene drives for a useful tool for population control of rodents.” 

See “Driving Down Pests

Clarification (July 11): The final sentence of the first paragraph of this article has been updated to clarify the outcome of the study.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.